Your browser doesn't support javascript.

Portal Regional da BVS

Informação e Conhecimento para a Saúde

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:


Adicionar mais destinatários
| |

Clinical effect of platelet rich fibrin in the treatment of periodontal intrabony defects. systematic review and meta-analysis

J. oral res. (Impresa); 6(5): 127-135, May 2017. ilus, tab
Artigo em Inglês | LILACS | ID: biblio-907733


There is currently no gold standard biomaterial for the treatment of periodontal intrabony defects (PIDs). One of the current options is the use of platelet-rich fibrin (PRF).


To determine the clinical effect of PRF in the treatment of PID through a systematic review and meta-analysis.


A literature search was conducted up to February 2017 in the following biomedical databases: Pubmed, Embase, Scielo, Science Direct, SIGLE, LILACS and in the Cochrane Central Register of Clinical Trials.The selection criteria included: randomized clinical trials published in the last 5 years, reporting clinical effects (probing depth, clinical insertion level or gingival recession), with a follow-up time equal to or greater than 6 months, and sample size larger than or equal to 10 patients reporting the use of PRF as a treatment for PID. The methodological quality of the studies was analyzed using the Cochrane Handbook of Systematic Reviews of Interventions as a reference.


The search strategy yielded 20 articles. A reduction in probing depth and an increase in clinical insertion level or a reduction in gingival recession is reported, when using PRF alone or in combination with another biomaterial or substance that stimulates tissue regeneration.


The literature suggests that the use of PRF in the treatment of PIDs has a beneficial clinical effect when compared to control treatments.
Biblioteca responsável: CL30.1